Alexander Randolph Advisory’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Sell
3,997
-56
-1% -$15.2K 0.92% 23
2025
Q4
$1.02M Sell
4,053
-11
-0.3% -$2.92K 0.85% 26
2025
Q3
$1.17M Sell
4,064
-60
-1% -$16.1K 0.96% 24
2025
Q2
$1.08M Sell
4,124
-100
-2% -$24.4K 0.97% 27
2025
Q1
$983K Sell
4,224
-42
-1% -$10.2K 0.96% 26
2024
Q4
$978K Sell
4,266
-7
-0.2% -$1.61K 0.91% 26
2024
Q3
$955K Buy
+4,273
New +$939K 0.85% 29
2024
Q2
Sell
-4,183
Closed -$914K 53
2024
Q1
$914K Buy
4,183
+37
+0.9% +$8.15K 0.8% 28
2023
Q4
$942K Buy
+4,146
New +$871K 0.86% 28

Other funds holding LH

Alexander Randolph Advisory's LH Position: Q1 2026 in Review

Alexander Randolph Advisory reduced its Labcorp (LH) stake by 1.4% in Q1 2026, selling an estimated $15.2K and leaving 3,997 shares worth $1.07M. The position accounts for 0.92% of the portfolio, ranked #23.

Alexander Randolph Advisory first reported a position in LH in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.17M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Alexander Randolph Advisory held 3,997 shares of Labcorp worth $1.07M as of Q1 2026.
  • Alexander Randolph Advisory sold 56 Labcorp shares in Q1 2026, an estimated $15.2K.
  • Labcorp made up 0.92% of Alexander Randolph Advisory's portfolio in Q1 2026, its #23 holding.
  • Alexander Randolph Advisory first reported a position in Labcorp in Q4 2023 and has held it in 9 quarters since.
  • Alexander Randolph Advisory's Labcorp position peaked at $1.17M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Alexander Randolph Advisory's 13F filing for Q1 2026, filed 7 May 2026.